Bleeding Is Bad…. Isn’t It?
- 11 December 2007
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 116 (24) , 2776-2778
- https://doi.org/10.1161/circulationaha.107.743534
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction?Circulation, 2007
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2007
- Predictors and Impact of Major Hemorrhage on Mortality Following Percutaneous Coronary Intervention from the REPLACE-2 TrialThe American Journal of Cardiology, 2007
- Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugsAmerican Heart Journal, 2007
- Impact of Major Bleeding on 30-Day Mortality and Clinical Outcomes in Patients With Acute Coronary SyndromesJournal of the American College of Cardiology, 2007
- Bivalirudin for Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2006
- Comparison of Fondaparinux and Enoxaparin in Acute Coronary SyndromesNew England Journal of Medicine, 2006
- A Comparison of the Clinical Impact of Bleeding Measured by Two Different Classifications Among Patients With Acute Coronary SyndromesJournal of the American College of Cardiology, 2006
- Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventionsThe American Journal of Cardiology, 2003
- Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary interventionJournal of the American College of Cardiology, 2001